Operative trends for pancreatic and hepatic malignancies during the COVID-19 pandemic

The COVID-19 pandemic disrupted routine health care, including many elective and non-cancer operations in the United States. Most hepato-pancreato-biliary malignancy patients require outpatient imaging, tissue sampling, and staging, and many undergo neoadjuvant therapy before operative intervention. The aims of this study were to evaluate the effect of the COVID-19 pandemic on hepato-pancreato-biliary oncologic operations and to determine whether trends in neoadjuvant therapy were altered by the pandemic.

Source: Surgery - April 6, 2024 Category: Surgery Authors: Alexander Manzella, Brett L. Ecker, Mariam F. Eskander, Miral S. Grandhi, Haejin In, Timothy Kravchenko, Russell C. Langan, Timothy Kennedy, H. Richard Alexander, Toni Beninato, Henry A. Pitt Source Type: research